These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 11573043)

  • 41. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma.
    Fraker DL; Norton JA; Alexander HR; Venzon DJ; Jensen RT
    Ann Surg; 1994 Sep; 220(3):320-8; discussion 328-30. PubMed ID: 7916560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.
    Norton JA; Venzon DJ; Berna MJ; Alexander HR; Fraker DL; Libutti SK; Marx SJ; Gibril F; Jensen RT
    Ann Surg; 2008 Mar; 247(3):501-10. PubMed ID: 18376196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients.
    Imamura M; Komoto I; Ota S; Hiratsuka T; Kosugi S; Doi R; Awane M; Inoue N
    World J Gastroenterol; 2011 Mar; 17(10):1343-53. PubMed ID: 21455335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].
    Mignon M
    Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.
    Kimura N; Hirata Y; Iwashiro N; Kijima H; Takayasu S; Yamagata S; Sakihara S; Uchino S; Ohara M
    Front Endocrinol (Lausanne); 2023; 14():1221514. PubMed ID: 37867522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of surgical resection for pancreatic neuroendocrine tumors.
    Doi R
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome.
    Yu F; Venzon DJ; Serrano J; Goebel SU; Doppman JL; Gibril F; Jensen RT
    J Clin Oncol; 1999 Feb; 17(2):615-30. PubMed ID: 10080607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical management of Zollinger-Ellison syndrome; state of the art.
    Morrow EH; Norton JA
    Surg Clin North Am; 2009 Oct; 89(5):1091-103. PubMed ID: 19836486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient.
    Thompson NW
    J Intern Med; 1995 Sep; 238(3):269-80. PubMed ID: 7673858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of patients with Zollinger-Ellison syndrome.
    Meko JB; Norton JA
    Annu Rev Med; 1995; 46():395-411. PubMed ID: 7598474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1.
    Thompson NW
    Surg Oncol Clin N Am; 1998 Oct; 7(4):881-91. PubMed ID: 9735139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The "serendipitous" surgical cure of the Zollinger-Ellison syndrome in a patient with multiple endocrine neoplasia type 1 despite an unsuspected diagnosis of either disease.
    Simeone DM; Scheiman JM; Thompson NW
    J Clin Gastroenterol; 2001 Mar; 32(3):268-71. PubMed ID: 11246362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).
    Cadiot G; Vuagnat A; Doukhan I; Murat A; Bonnaud G; Delemer B; Thiéfin G; Beckers A; Veyrac M; Proye C; Ruszniewski P; Mignon M
    Gastroenterology; 1999 Feb; 116(2):286-93. PubMed ID: 9922308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results of Duodenopancreatic Reoperations in Multiple Endocrine Neoplasia Type 1.
    Albers MB; Manoharan J; Bollmann C; Chlosta MP; Holzer K; Bartsch DK
    World J Surg; 2019 Feb; 43(2):552-558. PubMed ID: 30288555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical treatment and prognosis of gastrinoma.
    Norton JA
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):799-805. PubMed ID: 16253901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duodenal gastrinomas, duodenotomy, and duodenal exploration in the surgical management of Zollinger-Ellison syndrome.
    Thompson NW; Pasieka J; Fukuuchi A
    World J Surg; 1993; 17(4):455-62. PubMed ID: 8103249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
    Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resection of gastrinomas.
    Deveney CW; Deveney KE; Stark D; Moss A; Stein S; Way LW
    Ann Surg; 1983 Oct; 198(4):546-53. PubMed ID: 6138003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
    Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
    Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
    Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
    World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.